Tauopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-10-17
Clinical Trial Update: Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism Syndromes [NA]
Completed clinical trial evaluating 18F-APN-1607 PET imaging to assess tau distribution in tauopathy-related parkinsonism syndromes.